Literature DB >> 7507961

Cloning, genomic organization, and chromosomal localization of the Scya5 gene encoding the murine chemokine RANTES.

T M Danoff1, P A Lalley, Y S Chang, P S Heeger, E G Neilson.   

Abstract

RANTES is a member of the C-C subfamily of chemokines that functions as a proinflammatory chemoattractant for CD4+ T cells, monocytes, and eosinophils, and as an activator of basophils to release histamine. Like other members of the chemokine superfamily, RANTES has been implicated in a number of chronic inflammatory and autoimmune processes based on its function and its pattern of regulation. To begin study of the transcriptional regulation of RANTES, we have determined the genomic organization of the gene encoding the small inducible cytokine A5 (Scya5) and performed an initial analysis of its promoter elements. The Scya5 gene is located on chromosome 11. By Southern blot, it is a single-copy gene approximately 4.5 kb long composed of 3 exons. This chromosomal localization and pattern of genomic organization is conserved among the other C-C subfamily of chemokines. Primer extension analysis was used to identify the transcriptional initiation site that is located 27 bp downstream of a typical TATAA box. Sequence analysis of 1040 bp 5' to the start site of the Scya5 gene revealed a number of regulatory motifs that are also shared among the chemokine family including a PU.1 box, a NF-kappa B, and an IFN regulatory factor-1 response element. This region of genomic DNA was also cloned into a luciferase reporter vector. Transfection of this reporter construct into murine proximal tubular cells reveals that TNF-alpha can induce a transcriptional activation of the gene, as would be predicted from the rise in mRNA transcripts encoding RANTES in cells stimulated with TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507961

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Heritability of the maternal meiotic drive system linked to Om and high-resolution mapping of the Responder locus in mouse.

Authors:  F Pardo-Manuel De Villena; E de La Casa-Esperón; J W Williams; J M Malette; M Rosa; C Sapienza
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

2.  Expression of chemokine genes in murine macrophages infected with Orientia tsutsugamushi.

Authors:  N H Cho; S Y Seong; M S Huh; T H Han; Y S Koh; M S Choi; I S Kim
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis.

Authors:  V C Asensio; I L Campbell
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription.

Authors:  R Lin; C Heylbroeck; P Genin; P M Pitha; J Hiscott
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

5.  Cloning and characterization of the genomic DNA of the human MSSP genes.

Authors:  C Haigermoser; M Fujimoto; S M Iguchi-Ariga; H Ariga
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

6.  Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation.

Authors:  B D Ortiz; A M Krensky; P J Nelson
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

7.  Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.

Authors:  A H Lee; J H Hong; Y S Seo
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

8.  Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection.

Authors:  Sonia Lacroix-Lamandé; Roselyne Mancassola; Muriel Naciri; Fabrice Laurent
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

9.  Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection.

Authors:  Y H Su; X T Yan; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  CREB-binding protein/p300 are transcriptional coactivators of p65.

Authors:  M E Gerritsen; A J Williams; A S Neish; S Moore; Y Shi; T Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.